Companies
MaxSynBio (Max Planck)
Synthetic chloroplasts, vesicle chassis — Bottom-up cell assembly with photosynthetic energy generation.
- Country
- Germany
Coverage
| CN | EU | US | |
|---|---|---|---|
| genome-engineering | ✓ | ✓ | ✓ |
Regulatorsepaefsanmpa
Verifiable facts
| Fact | Value | Source |
|---|---|---|
| Affiliation | Max Planck Society and German Federal Ministry of Education and Research (BMBF) | renewable-carbon.eu · maxsynbio.mpg.de |
| Research focus | Bottom-up synthetic biology, construction of minimal cells/protocells, synthetic chloroplasts, metabolic cascades, artificial photosynthesis, CO2 capture and conversion, vesicle/droplet microcompartments | renewable-carbon.eu · maxsynbio.mpg.de |
| Facility | Microfluidic Systems Facility (Göttingen), Facility for Cell-Free Protein Expression (Martinsried), Dortmund Protein Facility | maxsynbio.mpg.de |
| Grant | Max-Planck-Gesellschaft (MPG) and Bundesministerium für Bildung und Forschung (BMBF) | renewable-carbon.eu · maxsynbio.mpg.de |
| Principal staff | Kai Sundmacher (Chief Coordinator), Petra Schwille (Chief Coordinator), Tobias Erb, Joachim P. Spatz, Katharina Landfester, Eberhard Bodenschatz, Stephan Herminghaus, Peter Dabrock | pubmed.ncbi.nlm.nih.gov · mpi-magdeburg.mpg.de |
| Publications | High, including papers in Nature Materials (e.g., Weiss et al., 2017) medium confidence | pubmed.ncbi.nlm.nih.gov |
Independent sources: mpi-magdeburg.mpg.de · pubmed.ncbi.nlm.nih.gov · renewable-carbon.eu
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Minimal genomes & synthetic cells | genome-engineering | High | → |
Compiled by BIOECON from primary sources.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.